Alterations in energy metabolism in cardiomyopathies
- 1 January 2007
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 39 (8) , 594-607
- https://doi.org/10.1080/07853890701618305
Abstract
Despite the fact that the heart requires huge amounts of energy to sustain contractile function, it has limited energy reserves and must therefore continually produce large amounts of adenosine triphosphate (ATP) to sustain function. Fatty acids are the primary energy substrate of the adult heart, with more than 60% of the energy normally obtained from the oxidation of fatty acids, the remainder coming from the metabolism of carbohydrates. Alterations in both the rates of ATP production and the type of energy substrate used by the heart can have consequences on contractile function, as well as on its ability to respond to energetic stresses. Switches in myocardial substrate utilization and energy production rates have been shown to occur in various cardiomyopathies, as well as in any subsequent heart failure. Heart failure is characterized by an inefficient pumping of the heart, which fails to meet the energy requirements of the body. A number of cardiomyopathies can lead to heart failure. This paper will review the alterations in energy metabolism that occur in a number cardiomyopathies, including ischemic and diabetic cardiomyopathies, as well as hypertrophic cardiomyopathies resulting from mutations in enzymes involved in energy metabolism, such as 5' adenosine monophosphate-activated protein kinase (AMPK).Keywords
This publication has 133 references indexed in Scilit:
- AMPK alterations in cardiac physiology and pathology: enemy or ally?The Journal of Physiology, 2006
- Insulin and Contraction Stimulate Exocytosis, but Increased AMP-activated Protein Kinase Activity Resulting from Oxidative Metabolism Stress Slows Endocytosis of GLUT4 in CardiomyocytesPublished by Elsevier ,2005
- Increased Rates of Fatty Acid Uptake and Plasmalemmal Fatty Acid Transporters in Obese Zucker RatsJournal of Biological Chemistry, 2001
- Structural Analysis of the Titin Gene in Hypertrophic Cardiomyopathy: Identification of a Novel Disease GeneBiochemical and Biophysical Research Communications, 1999
- Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditionsPotential for pharmacological interventionsPublished by Oxford University Press (OUP) ,1997
- Non-catalytic - and -Subunit Isoforms of the 5′-AMP-activated Protein KinaseJournal of Biological Chemistry, 1996
- Myocardial substrate metabolism: Implications for diabetic CardiomyopathyJournal of Molecular and Cellular Cardiology, 1995
- Regulation of fatty acid oxidation in the mammalian heart in health and diseaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Diabetes-induced abnormalities in the myocardiumLife Sciences, 1986
- Postnatal development of palmitate oxidation and mitochondrial enzyme activities in rat cardiac and skeletal muscleBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982